The expression levels of BNIP3 and GOT1 decreased gradually with the increase in grades, but RRM2 increased gradually with the increase in clinical grades and stages, which revealed that three target genes were closely related to tumor progression (Figures 11D–I). Here, BNIP3 is linked to neoplasm.